Article
Genomic profiling and the impact of MUC19 mutation in hepatoid adenocarcinoma of the stomach
19 Jul 2022
Abstract excerpt
Hepatoid adenocarcinoma (HAC) is a rare pathological subtype of extrahepatic tumor, featured by hepatoid differentiation and α-fetoprotein (AFP)-production [1, 2]. Hepatoid adenocarcinoma of the stomach (HAS), accounting for 0.3% to 1.0% of all gastric cancers (GCs), has attracted increasing attention due to its high degree of malignancy [3]. Compared with classic GC, HAS showed a higher rate of vascular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
